Robotic Assisted vs Custom Made Total Knee Arthroplasty
Knieathlon
Prospective Randomized Controlled Trial of Functionally Aligned Robotically Assisted Total Knee Arthroplasty vs Patient Specific Custom Made Total Knee Arthroplasty
1 other identifier
interventional
120
1 country
2
Brief Summary
The goal of this clinical trial is to compare Robotic Assisted, functionally aligned vs Custom Made Total Knee Arthroplasty in patients with knee osteoarthritis. The main questions it aims to answer are:
- Which implant/philosophy yields better clinical outcomes?
- Which implant/philosophy yields better satisfaction?
- Which system is more OR efficient? Participants will be followed for 2 years postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable knee-osteoarthritis
Started Mar 2024
Longer than P75 for not_applicable knee-osteoarthritis
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 28, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
January 28, 2025
January 1, 2025
3.1 years
February 5, 2024
January 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Clinical Outcome using the Forgotten Joint Score
Scale 0-100, higher score means better outcome
6 weeks, 3 months, 6 months, 12 months, 24 months
Secondary Outcomes (9)
Clinical outcomes using the Kujala anterior knee pain Score
preoperatively, 6 weeks, 3 months, 6 months, 12 months, 24 months
Patient satisfaction
preoperatively, 6 weeks, 3 months, 6 months, 12 months, 24 months
Visual analog pain (VAS) scale
preoperatively, 6 weeks, 3 months, 6 months, 12 months, 24 months
Surgical and total theatre time
Perioperative phase
Opioid use
Intraoperative stay
- +4 more secondary outcomes
Study Arms (2)
Custom made Total Knee Arthroplasty
EXPERIMENTALImplant used is a patient specific custom made total knee Origin (Symbios, Symbios Orthopédie SA, Avenue des Sciences 1, 1400 Yverdon-les-Bains, Switzerland)
Functionally aligned robotically assisted total knee arthroplasty
ACTIVE COMPARATORTotal Knee Implant Triathlon (Stryker, Kalamazoo, Michigan, U.S.) implanted using MAKO Rio Robotic Arm (Stryker)
Interventions
Total knee replacement, patient specific custom made total knee Origin (Symbios, Symbios Orthopédie SA, Avenue des Sciences 1, 1400 Yverdon-les-Bains, Switzerland)
Total knee replacement, Total Knee Implant Triathlon (Stryker, Kalamazoo, Michigan, U.S.) implanted using MAKO Rio Robotic Arm (Stryker), using functional alignment strategy
Eligibility Criteria
You may qualify if:
- \- The patient is a male or non-pregnant female between the ages of 40 and 90 years
- The patient requires a primary total knee replacement
- Patient is deemed appropriate for a cruciate retaining knee replacement
- The patient has a primary diagnosis of osteoarthritis (OA)
- The patient has intact collateral ligaments
- The patient is able to undergo CT scanning of the affected limb
- The patient has signed the study specific, ethics-approved, informed consent document
- The patient is willing and able to comply with the specified pre-operative and post-operative clinical and radiographic evaluations
You may not qualify if:
- \- The patient has a history of total, unicompartmental reconstruction or fusion of the affected joint
- Patient has had a previous osteotomy around the knee
- The patient is morbidly obese (BMI \> 41)
- The patient has a deformity which will require the use of stems, wedges or augments
- The patient has a varus deformity ≥ 15°
- The patient has a valgus deformity \>3°
- The patient has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device
- The patient is unable to speak German
- The patient is pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
AUVA UKH Steiermark Standort Graz
Graz, Styria, 8020, Austria
AUVA UKH Steiermark Standort Kalwang
Kalwang, Styria, 8775, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor, MD, PhD, EMBA
Study Record Dates
First Submitted
February 5, 2024
First Posted
February 28, 2024
Study Start
March 1, 2024
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
January 28, 2025
Record last verified: 2025-01